1. Home
  2. RVYL vs AIMD Comparison

RVYL vs AIMD Comparison

Compare RVYL & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVYL
  • AIMD
  • Stock Information
  • Founded
  • RVYL 2007
  • AIMD 1984
  • Country
  • RVYL United States
  • AIMD United States
  • Employees
  • RVYL N/A
  • AIMD N/A
  • Industry
  • RVYL Professional Services
  • AIMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • RVYL Consumer Discretionary
  • AIMD Health Care
  • Exchange
  • RVYL Nasdaq
  • AIMD Nasdaq
  • Market Cap
  • RVYL 8.3M
  • AIMD 7.5M
  • IPO Year
  • RVYL N/A
  • AIMD N/A
  • Fundamental
  • Price
  • RVYL $0.79
  • AIMD $0.47
  • Analyst Decision
  • RVYL Hold
  • AIMD
  • Analyst Count
  • RVYL 1
  • AIMD 0
  • Target Price
  • RVYL N/A
  • AIMD N/A
  • AVG Volume (30 Days)
  • RVYL 45.8K
  • AIMD 108.9K
  • Earning Date
  • RVYL 05-13-2025
  • AIMD 05-12-2025
  • Dividend Yield
  • RVYL N/A
  • AIMD N/A
  • EPS Growth
  • RVYL N/A
  • AIMD N/A
  • EPS
  • RVYL N/A
  • AIMD N/A
  • Revenue
  • RVYL $55,998,000.00
  • AIMD $20,729.00
  • Revenue This Year
  • RVYL $52.59
  • AIMD N/A
  • Revenue Next Year
  • RVYL N/A
  • AIMD N/A
  • P/E Ratio
  • RVYL N/A
  • AIMD N/A
  • Revenue Growth
  • RVYL N/A
  • AIMD N/A
  • 52 Week Low
  • RVYL $0.69
  • AIMD $0.40
  • 52 Week High
  • RVYL $2.66
  • AIMD $1.46
  • Technical
  • Relative Strength Index (RSI)
  • RVYL 35.85
  • AIMD 39.42
  • Support Level
  • RVYL $0.73
  • AIMD $0.46
  • Resistance Level
  • RVYL $1.18
  • AIMD $0.54
  • Average True Range (ATR)
  • RVYL 0.12
  • AIMD 0.05
  • MACD
  • RVYL -0.03
  • AIMD -0.00
  • Stochastic Oscillator
  • RVYL 10.96
  • AIMD 11.50

About RVYL Ryvyl Inc.

Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

Share on Social Networks: